MedPath

Biomarkers for Inborn Errors of Metabolism

Not Applicable
Conditions
Health Condition 1: E70-E88- Metabolic disorders
Registration Number
CTRI/2021/02/031462
Lead Sponsor
Centogene AG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Informed consent is obtained from the participant or from their parent/legal guardian, before any study related procedures

2. The participant aged between 2 months old and 40 years old

3. The diagnosis of an Inborn Error of Metabolism is genetically confirmed

Exclusion Criteria

1. Inability to provide informed consent

2. The participant is younger than 2 months old or older than 40 years old

3. The diagnosis of an Inborn Error of Metabolism (IEM) is not genetically confirmed

4. Previously enrolled in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To identify or monitor Inborn Error of Metabolism disease biomarkersTimepoint: 2 years and above
Secondary Outcome Measures
NameTimeMethod
To explore the clinical robustness, specificity, and long-term variability of Inborn Error of Metabolism disease biomarkersTimepoint: 2 years and above
© Copyright 2025. All Rights Reserved by MedPath